ABOVE & BEYOND CANCER INC

Balance Sheet
Fiscal Year: 2024
Jan 1, 2024 – Dec 31, 2024
Assets in 2024 (Year End)
$860,560
Cash & Equivalents
88%
Prepaid Expenses
7%
Investments
5%
Receivables (Non-Related)
<1%
Related-Party Receivables
0%
Inventories
0%
Property, Plant, & Equipment (net)
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$50,457
Payables & Accruals
53%
Deferred Revenue
47%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$553,846
$753,455
+36%
Receivables (Non-Related)
$25,000
$2,000
-92%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$2,396
$59,690
+2391%
Investments
$35,119
$45,415
+29%
Property, Plant, & Equipment (net)
-
$0
-
Other Assets
-
-
-
Total Assets
$616,361
$860,560
+40%
Liabilities
2023
2024
Change
Payables & Accruals
$17,614
$26,959
+53%
Grants Payable
-
-
-
Deferred Revenue
-
$23,498
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$17,614
$50,457
+186%
Net assets
2023
2024
Change
Restricted Net Assets
$55,117
$95,358
+73%
Unrestricted Net Assets
$543,630
$714,745
+31%
Net assets
2023
2024
Change
Net assets
+$598,747
+$810,103
+35%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)